Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × OTHER × Depressive Disorder, Major × Clear all

Phase

Phase NA 11 Phase 4 4 Phase 2 2 Phase EARLY_PHASE1 1 Phase 3 1 Phase 2/3 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 459 Colorectal Neoplasms 199 Neoplasms 197 Prostatic Neoplasms 178 Carcinoma, Non-Small-Cell Lung 162 Stomach Neoplasms 136 Carcinoma, Hepatocellular 125 Leukemia, Myeloid, Acute 124 Rectal Neoplasms 114 Multiple Myeloma 113 Lung Neoplasms 109 Nasopharyngeal Carcinoma 102 Colonic Neoplasms 90 Neoplasm Metastasis 86 Precursor Cell Lymphoblastic Leukemia-Lymphoma 75 Pancreatic Neoplasms 72 Lymphoma 71 Uterine Cervical Neoplasms 64 Leukemia 64 Head and Neck Neoplasms 64 Esophageal Neoplasms 63 Brain Neoplasms 63 Lymphoma, Large B-Cell, Diffuse 62 Lymphoma, Follicular 61 Ovarian Neoplasms 57 Recurrence 54 Squamous Cell Carcinoma of Head and Neck 48 Urinary Bladder Neoplasms 47 Lymphoma, Non-Hodgkin 47 Pain 45

Interventions

Interpersonal Psychotherapy 1 Escitalopram 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04973930 2025-05-13

IPT

New York State Psychiatric Institute

Phase 3 Suspended

Breast Neoplasms, Depressive Disorder, Major

Data powered by HemOnc (CC BY 4.0) Colophon ⚡